FDA OKs New Wearable Treatment for Parkinson’s Disease

[ad_1]

(MedPage Today) — The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson’s disease, Supernus Pharmaceuticals announced on Tuesday.
The wearable device is the first…

[ad_2]

Source link : https://www.medpagetoday.com/neurology/parkinsonsdisease/114074

Author :

Publish date : 2025-02-04 20:19:37

Copyright for syndicated content belongs to the linked Source.